MedPath

Impact on the Adverse Event (AE) Incidence of Two Types of Experience Feedback on AE Analyzed During Local Morbidity Mortality Reviews

Conditions
Hospital Adverse Event
Registration Number
NCT02771613
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

After implementing a French version of a trigger tool validated for computerized detection of adverse events in patient's medical record, the study will be performed in three parallel randomized arms of three identical departments (each steaming from 6 types of medical, surgical or obstetrical departments with a total of 18 departments involved). This three arms will be: no intervention, education of department's staff by multi professional in situ simulation (adapted to the discovered adverse events), or simple but large diffusion of results and decisions of Morbidity Mortality Reviews.

The interventions will be performed during a two-years period.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
144000
Inclusion Criteria
  • patients aged > 18 years old
  • patients hospitalized in the involved departments during the two-years intervention's period
Exclusion Criteria
  • patient aged < 18 years old
  • no other exclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Occurence of adverse events related to medical careDuring patient hospitalization, up to 2 years

Occurrence of any adverse effects detected by the trigger tool. Trigger tool is used to detect more patient's adverse events that voluntary medical report

Secondary Outcome Measures
NameTimeMethod
Contributive factors identificationDuring patient hospitalization, up to 2 years

Contributive factors of adverse events using the "ALARM Method". The Alarm Method allows to determine the contributive factors which together create the adverse patients events.

Severity of adverse events related to medical careDuring patient hospitalization, up to 2 years

Severity of any patient's adverse effect detected by trigger tool. Severity of adverse events is measured by a severity score scale.

Trial Locations

Locations (1)

Hospices Civils de Lyon - Direction DOQRU

🇫🇷

Lyon, France

Hospices Civils de Lyon - Direction DOQRU
🇫🇷Lyon, France
Bernard BUI-XUAN, MD, PhD
Principal Investigator
Philippe MICHEL, MD, PhD
Contact
+33 4 72 40 71 03
philippe.michel@chu-lyon.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.